Teach me epidemiology in detail and short from neetbpov

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive material from Park's textbook. Let me compile the full NEET PG epidemiology notes.

📚 EPIDEMIOLOGY - NEET PG Complete Notes

(Based on Park's Textbook of Preventive & Social Medicine)

1. DEFINITION & SCOPE

Definition (Last, 1988): "The study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to control of health problems."

Key Words:

Distribution = Who, where, when gets the disease (Descriptive epidemiology)
Determinants = Why and how (Analytical epidemiology)
Population = Unit of study (not individual - that's clinical medicine)

Epidemiology vs Clinical Medicine:

Feature	Epidemiology	Clinical Medicine
Unit of study	Defined population	Individual patient
Concern	Both sick and healthy	Sick patient
Output	Rates	Diagnosis/treatment
Approach	Investigator goes to community	Patient comes to doctor

2. AIMS OF EPIDEMIOLOGY (IEA - Three Main Aims)

Describe the distribution and magnitude of health/disease problems in human populations
Identify aetiological factors (risk factors) in pathogenesis of disease
Provide data for planning, implementation and evaluation of health services

Ultimate aim: Eliminate/reduce the health problem + promote health and well-being of society.

3. EPIDEMIOLOGICAL TRIAD (Triangle of Epidemiology)

Three components:

Host - human susceptibility
Agent - causative factor
Environment - external conditions

All three must interact for disease to occur. This is the classic model for infectious diseases.

4. BASIC MEASUREMENTS IN EPIDEMIOLOGY

A. Rate vs Ratio vs Proportion

Term	Definition	Example
Rate	Change per unit time; numerator included in denominator	Incidence rate
Ratio	Comparison of two quantities; numerator NOT in denominator	Sex ratio
Proportion	Numerator IS part of denominator; no time element	Prevalence

B. INCIDENCE RATE

Definition: Number of NEW cases occurring in a defined population during a specified period of time.

Formula: $$\text{Incidence} = \frac{\text{No. of new cases during given time period}}{\text{Population at-risk during that period}} \times 1000$$

Key features:

Only NEW cases
Must include unit of time (e.g., per 1000 per year)
Not influenced by duration of disease
Generally used for acute conditions

Special Incidence Rates:

Attack Rate (Case Rate)

Incidence rate during an epidemic (expressed as %)
Used when population is exposed for a limited period
Formula: (New cases / Population at risk) × 100

Secondary Attack Rate (SAR)

Number of cases that occur in a household within the maximum incubation period following exposure to a primary case
Formula: (New cases among contacts / Total susceptible contacts) × 100
Reflects infectivity of an agent
Excludes the primary case from denominator

C. PREVALENCE RATE

Definition: All current cases (old + new) existing at a given point in time or over a period of time.

Note: Prevalence is technically a ratio, not a true rate (no time element in numerator)

Types:

Type	Definition	Formula
Point Prevalence	All cases at one point in time	(All current cases / Population at that time) × 100
Period Prevalence	All cases during a defined period	(All cases during period / Mid-period population) × 100

When "prevalence" is used without qualification = Point prevalence

D. Relationship: Incidence & Prevalence

$$P = I \times D$$

Where P = Prevalence, I = Incidence, D = Mean duration of disease

Prevalence increases when: incidence ↑ OR duration ↑ (better treatment keeps patients alive longer)
Prevalence decreases when: incidence ↓ OR patients recover/die quickly

Incidence vs Prevalence:

Feature	Incidence	Prevalence
Cases	New only	Old + New
Time element	Yes	No (ratio)
Best for	Acute diseases, aetiology	Chronic diseases, planning
Use	Identifying risk factors	Manpower/bed planning

5. EPIDEMIOLOGICAL METHODS (Study Designs)

Epidemiological Studies
├── Observational
│   ├── Descriptive
│   └── Analytical
│       ├── Ecological/Correlational (unit = population)
│       ├── Cross-sectional/Prevalence (unit = individual)
│       ├── Case-control/Retrospective (unit = individual)
│       └── Cohort/Follow-up (unit = individual)
└── Experimental (Intervention)
    ├── Randomized Controlled Trial (unit = patients)
    ├── Field Trial (unit = healthy individuals)
    └── Community Trial (unit = communities)

A. DESCRIPTIVE EPIDEMIOLOGY

Studies disease distribution by Person, Place, Time (PPT).

Person: Age, sex, race, occupation, marital status, habits
Place: Country, urban/rural, geographic distribution
Time: Secular trends, cyclic changes, seasonal variation, point epidemics

Uses:

Provides clues for formulating aetiological hypotheses
Describes variation in disease by time, place, person
Provides background data for planning health services
Contributes to research

B. CASE-CONTROL STUDY (Retrospective Study)

Direction: Starts from effect → cause (backward)

Design: Select CASES (with disease) and CONTROLS (without disease) → look backward for exposure

2×2 Table:

	Cases (Disease +)	Controls (Disease -)
Exposed	a	b
Not Exposed	c	d

Measure of association: Odds Ratio (OR)

$$\text{OR} = \frac{ad}{bc}$$

OR Interpretation:

OR = 1 → No association
OR > 1 → Positive association (risk factor)
OR < 1 → Protective factor

Uses OR because you cannot calculate incidence from case-control studies (sample not representative of whole population).

Selection of Controls:

Hospital controls (risk: Berkesonian bias)
Relatives (siblings unsuitable for genetic studies)
Neighbourhood controls
General population controls

Biases in Case-Control:

Recall/Memory bias - Cases remember exposures better than controls
Selection bias - Cases/controls not representative of population
Berkesonian bias - Different hospital admission rates for different diseases
Interviewer bias - Eliminated by double-blinding
Confounding bias - Third variable related to both exposure and disease

Advantages:

Quick, inexpensive
Good for rare diseases and chronic diseases
Can study multiple exposures for one disease
Small sample needed

Disadvantages:

Recall bias
Selection of appropriate controls is difficult
Cannot calculate incidence or relative risk directly
Not suitable for rare exposures

C. COHORT STUDY (Prospective/Follow-up Study)

Direction: Starts from cause → effect (forward)

Design: Select exposed and non-exposed persons (free of disease) → follow up → observe who develops disease

Framework:

	Disease +	Disease -	Total
Exposed	a	b	a+b
Non-Exposed	c	d	c+d

Measure of association: Relative Risk (RR)

$$\text{RR} = \frac{\text{Incidence in exposed}}{\text{Incidence in non-exposed}} = \frac{a/(a+b)}{c/(c+d)}$$

Attributable Risk (AR): $$\text{AR} = \text{Incidence (exposed)} - \text{Incidence (non-exposed)}$$

Attributable Risk %: $$\text{AR%} = \frac{I_E - I_{NE}}{I_E} \times 100$$

Population Attributable Risk (PAR): $$\text{PAR} = \text{Incidence (total population)} - \text{Incidence (non-exposed)}$$

Types of Cohort Studies:

Prospective (concurrent): Exposure status identified now, followed into future (most common)
Retrospective (historical/non-concurrent): Both exposure and disease occurred in past; data from records

Advantages:

Can calculate incidence and RR directly
Establishes temporal sequence (cause before effect)
Can study multiple outcomes from one exposure
No recall bias
Best for common exposures

Disadvantages:

Expensive and time-consuming
Loss to follow-up (attrition bias)
Not suitable for rare diseases
Changes may occur in study population over time

COMPARISON: Case-Control vs Cohort

Feature	Case-Control	Cohort
Direction	Retrospective (effect→cause)	Prospective (cause→effect)
Starts with	Disease status	Exposure status
Measure	Odds Ratio (OR)	Relative Risk (RR)
Rare disease	Yes	No
Rare exposure	No	Yes
Time/Cost	Short/Cheap	Long/Expensive
Incidence	Cannot calculate	Can calculate
Bias	Recall, Berkesonian	Attrition/loss to follow-up
Best example	Cancer + carcinogen	Framingham Heart Study

D. RANDOMIZED CONTROLLED TRIAL (RCT)

Gold standard experimental study
Patients randomized into experimental and control groups
Investigator manipulates an intervention

Steps:

Draw up a protocol
Select reference and experimental populations
Randomization
Manipulation/intervention
Follow-up
Assessment of outcome

Blinding:

Single blind - Only patient is unaware of group allocation
Double blind - Both patient and investigator are unaware (eliminates interviewer and patient bias)
Triple blind - Patient, investigator, and data analyst are unaware

Crossover trial: Each subject acts as own control - both treatments given, separated by washout period.

6. RELATIVE RISK vs ODDS RATIO

Measure	Study	Formula	When OR ≈ RR
RR (Relative Risk)	Cohort	Incidence(exposed) / Incidence(non-exposed)	-
OR (Odds Ratio)	Case-control	ad/bc	When disease is rare (<10%)

RR = 1 → No association
RR > 1 → Positive association
RR < 1 → Protective (e.g., vaccine)

7. ASSOCIATION AND CAUSATION (Bradford Hill Criteria)

Types of association:

Spurious association - Due to bias/chance (e.g., hospital perinatal mortality paradox)
Indirect association - Due to confounding variable
Direct/Causal association - True cause-effect relationship

Bradford Hill's Criteria for Causation (9 Criteria):

#	Criterion	Meaning
1	Temporal association	Cause must precede effect - most important/essential
2	Strength of association	Higher RR = stronger evidence
3	Dose-response	More exposure → more disease
4	Consistency	Same finding in different populations/settings
5	Specificity	One cause → one disease
6	Biological plausibility	Makes biological sense
7	Coherence	Does not conflict with known facts
8	Experimental evidence	Removal of factor reduces disease
9	Analogy	Similar associations exist elsewhere

Mnemonic: Truly Strong Dose Consistently Specific Biology Coherently Experiments Analogize = TS-DC-SB-CEA

Only temporal association is ESSENTIAL. The others support causation but none is individually sufficient.

8. SCREENING

Definition (WHO): "The presumptive identification of unrecognized disease or defect by means of tests, examinations or other procedures which can be applied rapidly."

Screening vs Diagnostic Test:

Feature	Screening	Diagnostic
Applied to	Apparently healthy	Sick/symptomatic
Applied in	Groups	Individual patients
Cost	Less expensive	More expensive
Accuracy	Less accurate	More accurate
Basis for treatment	No	Yes
Initiative	From investigator	From patient

Validity of Screening Test:

Using 2×2 table (Disease = Gold Standard):

	Disease +	Disease -
Test +	TP (a)	FP (b)
Test -	FN (c)	TN (d)

$$\text{Sensitivity} = \frac{a}{a+c} \times 100 \quad (\text{True Positives / All with disease})$$

$$\text{Specificity} = \frac{d}{b+d} \times 100 \quad (\text{True Negatives / All without disease})$$

$$\text{PPV} = \frac{a}{a+b} \times 100 \quad (\text{True Positives / All positive tests})$$

$$\text{NPV} = \frac{d}{c+d} \times 100 \quad (\text{True Negatives / All negative tests})$$

Key relationships:

Sensitivity and specificity are inversely related
High sensitivity = Few false negatives (good for ruling OUT disease - SnNOUT)
High specificity = Few false positives (good for ruling IN disease - SpPIN)
PPV and NPV depend on prevalence of disease
Sensitivity and specificity are independent of prevalence

Lead time: The period between detection by screening and usual clinical presentation. Screening benefit must exceed lead time bias.

9. HERD IMMUNITY

Definition: The resistance of a group/community to invasion and spread of an infectious agent, based on the immunity of a high proportion of members.

$$\text{Herd Immunity Threshold (HIT)} = 1 - \frac{1}{R_0}$$

R₀ = Basic reproduction number (average cases generated by one case)
Higher R₀ → Higher HIT needed

Disease	R₀	HIT Required
Measles	12-18	92-95%
Polio	5-7	80-85%
Smallpox	5-7	80-85%
COVID-19	2-3	50-67%

10. GENERATION TIME vs SERIAL INTERVAL

Generation time: Time interval between receipt of infection by a host and maximal infectivity of that host
Serial interval: Time between onset of symptoms in primary case and onset in secondary case
Incubation period: Time between exposure and onset of symptoms

11. QUICK REVISION TABLE: Study Designs

Study	Type	Direction	Measure	Rare Disease	Time
Cross-sectional	Observational	No time element	Prevalence	No	Quickest
Ecological	Observational	Population level	Correlation	-	Quick
Case-control	Analytical	Retrospective	OR	Yes	Short
Cohort	Analytical	Prospective	RR, AR	No	Long
RCT	Experimental	Prospective	RR	No	Long
Field trial	Experimental	Prospective	-	No	Long

12. HIGH-YIELD NEET PG ONE-LINERS

Epidemiology unit of study = Defined population (not individual)
Incidence = NEW cases; requires time in expression
Prevalence = ALL current cases; is a ratio (not a rate)
P = I × D (Prevalence = Incidence × Duration)
Attack rate = Incidence during epidemic (%)
SAR excludes primary case from denominator
OR used in case-control studies; RR in cohort studies
OR ≈ RR when disease is rare (<10%)
Bradford Hill - temporal association is the only essential criterion
Recall bias is the main bias of case-control studies
Attrition/loss to follow-up is main problem in cohort studies
Berkesonian bias = hospital admission rate bias in case-control
Sensitivity = detects true cases = rules OUT disease (SnNOUT)
Specificity = detects true non-cases = rules IN disease (SpPIN)
PPV and NPV depend on prevalence; sensitivity and specificity do not
Framingham study = most famous prospective cohort study
RCT = gold standard for intervention/therapy evaluation
Double blind RCT = eliminates interviewer + patient bias
Screening is not a diagnostic test; just an initial examination
Lead time = period gained by early detection through screening
Herd immunity - Measles requires highest coverage (~95%)
Web of causation = MacMahon's model for multifactorial disease
Ecological fallacy = applying group-level findings to individuals
Cross-sectional study = cannot establish temporal association (chicken-and-egg problem)
Field trial = experimental study in healthy individuals (e.g., vaccine trials)

Source: Park's Textbook of Preventive and Social Medicine, 24th Edition

This covers all the core epidemiology topics tested in NEET PG/NEXT. Focus especially on:

Study design comparison (very frequently tested)
OR vs RR formulas and interpretation
Sensitivity/specificity/PPV/NPV calculations
Bradford Hill criteria (temporal association = essential)
Incidence vs Prevalence relationship
Types of bias in each study design

Create a flowchart: How to choose the right epidemiological study design

Generating Image

A clean, detailed medical flowchart titled "How to Choose the Right Epidemiological Study Design" for NEET PG students. The flowchart starts with the question "What is your research objective?" at the top, then branches through a series of diamond-shaped decision boxes with YES/NO paths leading to rectangular endpoint boxes naming the study design. Decision questions include: "Do you want to describe disease distribution?" → YES → "Descriptive Study (Person, Place, Time)"; NO → "Do you want to test a hypothesis?"; "Can you randomize/intervene?" → YES → "Experimental Study" → branches to "Patients as subjects? → RCT", "Healthy individuals? → Field Trial", "Communities? → Community Trial"; NO → "Observational Analytical Study"; "Is the disease rare?" → YES → "Case-Control Study (OR, Retrospective)"; NO → "Is the exposure rare?" → YES → "Cohort Study (RR, Prospective)"; NO → "Need quick prevalence data?" → YES → "Cross-Sectional Study"; NO → "Are you studying population-level data?" → YES → "Ecological/Correlational Study". Each endpoint box includes key features: measure used (OR/RR/Prevalence), direction (prospective/retrospective), and one key advantage. Color-coded: blue for decision diamonds, green for study design boxes, yellow for key measures. Professional medical education style with clear arrows and labels.

Here's your flowchart! Here's how to read it quickly:

The decision logic in order:

Describe disease? → Descriptive Study (PPT)
Can you intervene/randomize? → Experimental (RCT / Field Trial / Community Trial)
Disease is rare? → Case-Control (measure: OR, direction: retrospective)
Exposure is rare? → Cohort Study (measure: RR, direction: prospective)
Need quick prevalence snapshot? → Cross-Sectional Study
Population-level data only? → Ecological Study

Quick memory tip for NEET PG:

Rare Disease → Case-control (D→C = backwards)
Rare Exposure → Cohort (E→C = forwards)
OR = case-control | RR = cohort
RCT = gold standard whenever randomization is ethically possible

This is a shared conversation. Sign in to Orris to start your own chat.